Biomerica

BMRA

----

Current ValuationThe current P/E ratio is -2.28, within the reasonable range, cheaper than 48.77% of the time in the past 5 years, and the industry ranks 98/173, the industry Median -0.86.

-2.28xP/E

Stock price$1.85Earnings per share$-0.81

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-12.30x	141.71%	$13.07B
GKOSUSGlaukos	-51.70x	75.37%	$9.72B
TFXUSTeleflex	-5.36x	118.39%	$5.53B
IRTCUSIRhythm	-256.81x	71.47%	$3.58B
PLSEUSPulse Biosciences	-39.58x	26.85%	$3.17B
AXGNUSAxogen	-60.55x	16.18%	$2.03B
BFLYUSButterfly Network	-25.79x	31.45%	$1.93B
ASSTUSStrive	-1.71x	63.23%	$1.67B
NVCRUSNovocure	-11.03x	1.23%	$1.64B
ATECUSAlphatec	-14.69x	41.67%	$1.62B
KMTSUSKestra Medical Tech	-10.65x	0.94%	$1.60B
DRTSUSAlpha Tau Medical	-12.26x	--	$1.13B
TNDMUSTandem Diabetes	-17.85x	77.60%	$1.13B
ENOVUSEnovis	-1.03x	100.97%	$1.13B
AORTUSArtivion	-332.78x	266.67%	$1.06B
IARTUSIntegra LifeSciences	-141.96x	108.85%	$1.03B
PRCTUSPROCEPT BioRobotics	-9.17x	3.47%	$1.01B
CBLLUSCeribell	-14.56x	35.15%	$960.99M
QDELUSQuidelOrtho	-0.84x	75.33%	$885.31M
SIBNUSSI-BONE	-60.28x	8.85%	$882.03M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.